What is a stock summary page? Click here for an overview.
Business Description
BioRegenx Inc
NAICS : 923120
SIC : 7372
ISIN : US31772N1000
Description
BioRegenx Inc is redefining health intelligence with new patented technologies and artificial intelligence. Its specialize in developing intellectual property (IP) and are engaged in regenerative biotherapeutics, anti-aging, artificial intelligence (AI) for healthcare and bioinformatics for public and private transportation. The primary focus involves acquiring or developing non-invasive medical and wellness devices capable of efficiently recording, storing, and analyzing extensive datasets.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.16 | |||||
| Debt-to-EBITDA | -13.29 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -0.03 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -26 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.33 | |||||
| 9-Day RSI | 45.79 | |||||
| 14-Day RSI | 47.8 | |||||
| 3-1 Month Momentum % | -30.77 | |||||
| 6-1 Month Momentum % | -28 | |||||
| 12-1 Month Momentum % | -80.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.11 | |||||
| Quick Ratio | 0.06 | |||||
| Cash Ratio | 0.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.1 | |||||
| Shareholder Yield % | -11.23 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 69.19 | |||||
| Operating Margin % | 163.42 | |||||
| Net Margin % | 226.35 | |||||
| FCF Margin % | -90.49 | |||||
| ROE % | -21.2 | |||||
| ROA % | -16.84 | |||||
| ROIC % | -11.15 | |||||
| 3-Year ROIIC % | -441.67 | |||||
| ROC (Joel Greenblatt) % | -533.46 | |||||
| ROCE % | -20.11 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 2.6 | |||||
| PE Ratio without NRI | 2.6 | |||||
| PB Ratio | 0.93 | |||||
| Price-to-Free-Cash-Flow | 2.6 | |||||
| Price-to-Operating-Cash-Flow | 2.6 | |||||
| EV-to-EBIT | -8.01 | |||||
| EV-to-EBITDA | -89.62 | |||||
| EV-to-Revenue | -17.47 | |||||
| EV-to-FCF | 19.31 | |||||
| Price-to-Projected-FCF | 1.3 | |||||
| Earnings Yield (Greenblatt) % | -12.48 | |||||
| FCF Yield % | 6.05 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BRGX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BioRegenx Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | -0.831 | ||
| EPS (TTM) ($) | 0.005 | ||
| Beta | -3.51 | ||
| 3-Year Sharpe Ratio | 0.59 | ||
| 3-Year Sortino Ratio | 2.37 | ||
| Volatility % | 174.72 | ||
| 14-Day RSI | 47.8 | ||
| 14-Day ATR ($) | 0.003804 | ||
| 20-Day SMA ($) | 0.015441 | ||
| 12-1 Month Momentum % | -80.13 | ||
| 52-Week Range ($) | 0.00898 - 0.0453 | ||
| Shares Outstanding (Mil) | 956.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BioRegenx Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioRegenx Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
BioRegenx Inc Frequently Asked Questions
What is BioRegenx Inc(BRGX)'s stock price today?
The current price of BRGX is $0.01. The 52 week high of BRGX is $0.05 and 52 week low is $0.01.
When is next earnings date of BioRegenx Inc(BRGX)?
The next earnings date of BioRegenx Inc(BRGX) is .
Does BioRegenx Inc(BRGX) pay dividends? If so, how much?
BioRegenx Inc(BRGX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers